Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

Transurethral Prostatectomy with the Bipolar Plasmakinetic Technique for Benign Prostate Hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Transurethral Resection of Prostate with Bipolar Plasmakinetic for the Treatment of High Risk Benign Prostatic Hyperplasia Patients

Transurethral Resection of the Hyperplastic Prostate and Bladder Tumor Using Bipolar Plasmakinetic Technique

Five-Year Follow-Up Study of Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia.

Transurethral Plasmakinetic Resection of Prosate for Benign Prostatic Hyperplasia(274 Cases)

Efficacy and Safety of Plasmakinetic Resection of the Prostate in Patients with a Prostate Gland Larger Than 80 Cc: 30-Month Follow-Up Results.

[Therapeutic Efficacy of Bipolar Plasmakinetic Technique Compared with Transurethral Resection on Benign Prostate Hyperplasia].

A Comparative Study of Transurethral Plasmakinetic Resection Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Two-year Outcome of High-risk Benign Prostate Hyperplasia Patients Treated with Transurethral Prostate Resection by Plasmakinetic or Conventional Procedure

Transurethral Resection of Hyperplastic Prostate Using Bipolar Plasmakinetic Technique

Transurethral plasma kinetic enucleation of prostate for benign prostatic hyperplasia

Comparison of transurethral plasmakinetic resection of the prostate and transvesical prostectomy for the treatment of large volume benign prostatic hyperplasia

Comparison of efficacy and safety between transurethral plasma kinetic resection of prostate and conventional transurethral resection of prostate for treatment of benign prostate hyperplasia

Plasmakinetic Resection Technology for the Treatment of Benign Prostatic Hyperplasia: Evidence from a Systematic Review and Meta-Analysis

Impact of Plasmakinetic Resection of Prostate on Sexual Function in Patients with Benign Prostatic Hyperplasia

The Clinical Safety and Efficacy of PKRP and TURP in the Treatment of Patients with Benign Prostatic Hyperplasia Prostate(volume>60 Ml):A Compared Study

Transurethral bipolar plasmakinetic resection combined with 2 μm laser vaporization in the treatment of larger-volumed benign prostate hyperplasia

Comparative Analysis of the Efficacy and Safety of Transurethral Plasmakinetic Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia of Different Volumes